𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The prognostic value of estrogen receptor determinations in patients with primary breast cancer: An update

✍ Scribed by Philip Furmanski; Dwight E. Saunders; Samuel C. Brooks; Marvin A. Rich

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
265 KB
Volume
46
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Distinct prognostic values of p53 mutati
Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers
✍ Masato Takahashi; Hidefumi Tonoki; Mitsuhiro Tada; Haruhiko Kashiwazaki; Keiji F πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 117 KB πŸ‘ 1 views

A total of 76 primary breast cancers were screened for p53 mutations using the yeast p53 functional assay, and the mutations were determined by DNA sequencing. Clonal mutations of p53 were detected in 30 tumors (39%). Immunohistochemical staining for nuclear p53 accumulation performed on the yeast a

Evaluation of a displacement assay with
Evaluation of a displacement assay with tamoxifen as prognostic indicator in breast-cancer patients with estrogen-receptor-positive tumors
✍ Emanuel Levin; Andrea M. Actis; Silvana Caruso; Hugo Gass; Raquel Romero; NicolΓ‘ πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 95 KB πŸ‘ 2 views

A displacement assay with tamoxifen, based on the relative binding affinity of tamoxifen and estradiol for the estrogen receptor (ER), was proposed in 1990 as prognostic indicator for breast-cancer patients. Validation of its predictive results in relation to the outcome of 73 patients with ER Ψ‰ tum